University of California, San Diego

Measurement of the Spectral Shape of the beta-Decay of Xe-137 to the Ground State of Cs-137 in EXO-200 and Comparison with Theory (2020) Al Kharusi S, Anton G, Badhrees I, Barbeau PS, Beck D, Belov V, Bhatta T, et al. Journal article An allosteric modulator binds to a conformational hub in the beta(2) adrenergic receptor (2020) Liu X, Kaindl J, Korczynska M, Stößel A, Dengler D, Stanek M, Hübner H, et al. Journal article When function follows form: Nuclear compartment structure and the epigenetic landscape of the aging neuron (2020) Schlachetzki JCM, Toda T, Mertens J Journal article Human Herpesvirus-6 Reactivation, Mitochondrial Fragmentation, and the Coordination of Antiviral and Metabolic Phenotypes in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. (2020) Schreiner P, Harrer T, Scheibenbogen C, Lamer S, Schlosser A, Naviaux R, Prusty BK Journal article A monocyte gene expression signature in the early clinical course of Parkinson's disease (vol 8, 10757, 2018) (2020) Winner B, Schlachetzki JC, Prots I, Tao J, Chun HB, Saijo K, Gosselin D, et al. Journal article, Erratum Chronic Peripheral Inflammation Causes a Region-Specific Myeloid Response in the Central Nervous System (2020) Süß P, Hoffmann A, Rothe T, Ouyang Z, Baum W, Staszewski O, Schett G, et al. Journal article Consensus guidelines for the definition, detection and interpretation of immunogenic cell death (2020) Galluzzi L, Vitale I, Warren S, Adjemian S, Agostinis P, Martinez AB, Chan TA, et al. Journal article, Review article The giant outburst of 4U 0115+634 in 2011 with Suzaku and RXTE: Minimizing cyclotron line biases (2020) Kühnel M, Kreykenbohm I, Ferrigno C, Pottschmidt K, Marcu-Cheatham DM, Fuerst F, Rothschild RE, et al. Journal article Bimekizumab in patients with active psoriatic arthritis: results from a 48-week, randomised, double-blind, placebo-controlled, dose-ranging phase 2b trial (2020) Ritchlin CT, Kavanaugh A, Merola JF, Schett G, Scher JU, Warren RB, Gottlieb AB, et al. Journal article Cemiplimab in locally advanced cutaneous squamous cell carcinoma: results from an open-label, phase 2, single-arm trial (2020) Migden MR, Khushalani NI, Chang ALS, Lewis KD, Schmults CD, Hernandez-Aya L, Meier F, et al. Journal article